^
KRAS mutation
|
Juvenile Myelomonocytic Leukemia
|
KRAS mutation
|
Juvenile Myelomonocytic Leukemia
|
decitabine Sensitive: C4 – Case Studies
|
decitabine Sensitive: C4 – Case Studies
|
ETV6-FLT3 fusion
|
Juvenile Myelomonocytic Leukemia
|
ETV6-FLT3 fusion
|
Juvenile Myelomonocytic Leukemia
|
gilteritinib Sensitive: C4 – Case Studies
|
gilteritinib Sensitive: C4 – Case Studies
|
SETBP1 mutation + NRAS mutation
|
Juvenile Myelomonocytic Leukemia
|
SETBP1 mutation + NRAS mutation
|
Juvenile Myelomonocytic Leukemia
|
trametinib Sensitive: D – Preclinical
|
trametinib Sensitive: D – Preclinical
|
